Survival after cardiac transplantation in patients with hypertrophic cardiomyopathy

Circulation: Heart Failure

Volumn 3, Issue 5, 2010, Pages 574-579

  Maron, Martin S ^a   Kalsmith, Benjamin M ^a   Udelson, James E ^a   Li, Wenjun ^b   DeNofrio, David ^a  

^a TUFTS MEDICAL CENTER   (United States)

^b UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

Author keywords

Heart failure; Heart transplantation; Hypertrophic cardiomyopathy

Indexed keywords

ADULT; ARTICLE; CARDIOMYOPATHY; CONGESTIVE CARDIOMYOPATHY; CONTROLLED STUDY; DEMOGRAPHY; FEMALE; FOLLOW UP; GRAFT RECIPIENT; GRAFT SURVIVAL; HEART TRANSPLANTATION; HUMAN; HYPERTROPHIC CARDIOMYOPATHY; ISCHEMIC CARDIOMYOPATHY; LOG RANK TEST; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PRIORITY JOURNAL; PROGNOSIS; PROPORTIONAL HAZARDS MODEL; RESTRICTIVE CARDIOMYOPATHY; SURVIVOR; UNITED STATES; CHI SQUARE DISTRIBUTION; COMORBIDITY; MIDDLE AGED; MORTALITY; PREVALENCE; REGISTER; STATISTICAL MODEL; SURVIVAL RATE; TREATMENT OUTCOME;

ADULT; CARDIOMYOPATHY, HYPERTROPHIC; CHI-SQUARE DISTRIBUTION; COMORBIDITY; FEMALE; HEART TRANSPLANTATION; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; PREVALENCE; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; REGISTRIES; SURVIVAL RATE; TREATMENT OUTCOME; UNITED STATES;

EID: 77957921170     PISSN: 19413289     EISSN: 19413297     Source Type: Journal    
DOI: 10.1161/CIRCHEARTFAILURE.109.922872     Document Type: Article

References (13)

1. Elliott PM, Gimeno JR, Thaman R, Shah J, Ward D, Dickie S, Tome Esteban MT, McKenna WJ. Historical trends in reported survival rates in patients with hypertrophic cardiomyopathy. Heart. 2006;92:785-791. (Pubitemid 43799212)
2. Harris KM, Spirito P, Maron MS, Zenovich AG, Formisano F, Lesser JR, Mackey-Bojack S, Manning WJ, Udelson JE, Maron BJ. Prevalence, clinical profile, and significance of left ventricular remodeling in the end-stage phase of hypertrophic cardiomyopathy. Circulation. 2006;114:216-225. (Pubitemid 44297115)
3. Maron BJ. Hypertrophic cardiomyopathy: a systematic review. J Am Med Assoc. 2002;287:1308-1320. (Pubitemid 34250486)
4. Maron BJ, McKenna WJ, Danielson GK, Kappenberger LJ, Kuhn HJ, Seidman CE, Shah PM, Spencer WH III, Spirito P, Ten Cate FJ, Wigle ED. American College of Cardiology/European Society of Cardiology clinical expert consensus document on hypertrophic cardiomyopathy. A report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents and the European Society of Cardiology Committee for Practice Guidelines. J Am Coll Cardiol. 2003;42:1687-1713. (Pubitemid 37383745)
5. Spirito P, Seidman CE, McKenna WJ, Maron BJ. The management of hypertrophic cardiomyopathy. N Engl J Med. 1997;336:775-785. (Pubitemid 27113973)
6. Wigle ED, Rakowski H, Kimball BP, Williams WG. Hypertrophic cardiomyopathy: clinical spectrum and treatment. Circulation. 1995;92:1680-1692.
7. Biagini E, Spirito P, Leone O, Picchio FM, Coccolo F, Ragni L, Lofiego C, Grigioni F, Potena L, Rocchi G, Bacchi-Reggiani L, Boriani G, Prandstraller D, Arbustini E, Branzi A, Rapezzi C. Heart transplantation in hypertrophic cardiomyopathy. Am J Cardiol. 2008;101:387-392. (Pubitemid 351187753)
8. Coutu M, Perrault LP, White M, Pelletier GB, Racine N, Poirier NC, Carrier M. Cardiac transplantation for hypertrophic cardiomyopathy: a valid therapeutic option. J Heart Lung Transplant. 2004;23:413-417.
9. Lietz K, Miller LW. Improved survival of patients with end-stage heart failure listed for heart transplantation: analysis of organ procurement and transplantation network/U. S. United Network of Organ Sharing data, 1990 to 2005. J Am Coll Cardiol. 2007;50:1282-1290. (Pubitemid 47405140)
10. Biagini E, Coccolo F, Ferlito M, Perugini E, Rocchi G, Bacchi-Reggiani L, Lofiego C, Boriani G, Prandstraller D, Picchio FM, Branzi A, Rapezzi C. Dilated hypokinetic evolution of hypertrophic cardiomyopathy: prevalence, incidence, risk factors, and prognostic implications in pediatric and adult patients. J Am Coll Cardiol. 2005;46:1543-1550. (Pubitemid 41446193)
11. Maron BJ, Olivotto I, Spirito P, Casey SA, Bellone P, Gohman TE, Graham KJ, Burton DA, Cecchi F. Epidemiology of hypertrophic cardiomyopathy-related death: revisited in a large non-referral-based patient population. Circulation. 2000;102:858-864.
12. Thaman R, Gimeno JR, Murphy RT, Kubo T, Sachdev B, Mogensen J, Elliott PM, McKenna WJ. Prevalence and clinical significance of systolic impairment in hypertrophic cardiomyopathy. Heart. 2005;91:920-925. (Pubitemid 40874082)
13. Spirito P, Maron BJ, Bonow RO, Epstein SE. Occurrence and significance of progressive left ventricular wall thinning and relative cavity dilatation in hypertrophic cardiomyopathy. Am J Cardiol. 1987;60:123-129. (Pubitemid 17137391)